Document Detail

A Comprehensive Evaluation of Rhythm Monitoring Strategies for the Detection of Atrial Fibrillation Recurrence: Insights from 647 Continuously Monitored Patients and Implications for Monitoring After Therapeutic Interventions.
MedLine Citation:
PMID:  22824434     Owner:  NLM     Status:  Publisher    
BACKGROUND: Intermittent rhythm monitoring (IRM) to detect atrial fibrillation (AF) recurrence is employed to evaluate the success of therapeutic interventions. In a large population of continuously monitored (CM) patients, we investigated the sensitivity of various frequency and duration IRM strategies on the detection of AF recurrence, the dynamics behind AF recurrence detection and describe measures to evaluate temporal AF recurrence. METHODS AND RESULTS: Rhythm histories of 647 patients (mean AF burden: 0.12±0.22; median: 0.014; 687 patient*years) with implantable CM devices were reconstructed and analyzed. Using computationally intensive simulation, the sensitivity of IRM of various frequencies and durations on the identification of AF recurrence was evaluated. Prolonged duration IRM was superior to shorter IRM (p<0.0001). However, even with aggressive IRM strategies, AF recurrence was not detected in a great proportion of patients. The temporal AF burden aggregation (AF density) was directly related to IRM sensitivity (p<0.0001). Even at similar AF burdens, patients with high density AF required higher frequency or prolonged duration IRM to achieve the same sensitivity as in low density AF (p<0.0001). Patients with high density, low burden AF benefit the most from CM for detection of AF recurrence. CONCLUSIONS: IRM follow up is significantly inferior to CM. IRM strategies will not identify AF recurrence in a great proportion of patients at risk. Temporal AF characteristics play a significant role in AF recurrence detection using IRM. For the scientific, evidence based evaluation of AF treatments, CM should be strongly recommended. Prospective studies are required to evaluate if CM to guide clinical management can also improve patient outcomes. CLINICAL TRIAL REGISTRATION INFORMATION:; Identifier: NCT00806689.
Efstratios I Charitos; Ulrich Stierle; Paul D Ziegler; Malte Baldewig; Derek R Robinson; Hans-Hinrich Sievers; Thorsten Hanke
Related Documents :
8119204 - Prospective evaluation of endoscopic ultrasonography and endoscopic retrograde cholangi...
18061714 - Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune ...
22075154 - Circulating lipoprotein-associated phospholipase a2 in high-grade carotid stenosis: a n...
11192324 - Comparison of two tubeless function tests in the assessment of mild-to-moderate exocrin...
1078774 - Superficial microcystic corneal dystrophy.
3474154 - Restoration of active haemopoiesis in a patient with myelofibrosis and subsequent termi...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-7-23
Journal Detail:
Title:  Circulation     Volume:  -     ISSN:  1524-4539     ISO Abbreviation:  -     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-7-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
1 University of Luebeck, Luebeck, Germany;
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  AF Monitoring: Mathematics Meets Real Life.
Next Document:  Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary Stents: 1-Year Outcomes from the Ran...